Cellectar Biosciences, Inc. (NASDAQ:CLRB) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 12.32% to close at $1.55 with the total traded volume of 17.61 Million shares. . The firm has institutional ownership of 15.50%, while insider ownership included 2.90%. CLRB attains analyst recommendation of 1.00 with week performance of 21.09%.
To have technical views, liquidity ratio of a company calculated as 4.30 to match up with its debt to equity ratio of 0.03. The float short ration was 5.71%; as compared to Short Ratio were 1.24. The firm has institutional ownership of 15.50%, while insider ownership included 2.90%. CLRB attains analyst recommendation of 1.00 with week’s performance of 21.09%.
Under investment valuation analysis, Ocular Therapeutix, Inc. (NASDAQ:OCUL) presented as an active mover, it has floated short ration of 24.00%, hold to candle to sentiment indicator of Short Ratio, which was 5.86. Shares dropped -9.01% to trade at $6.87 in most recent trading session.
The co stands at price to sale ratio of 97.71 that signifies the value placed on each dollar of a firm’s sales or incomes; it is most relevant ratio to compare companies in similar sector. It has price to book ratio of 2.74, which gauges the market price of a share over its book value.
The firm has price volatility of 6.27% for a week and 5.80% for a month. Narrow down focus to firm performance, its weekly performance was -12.93% and monthly performance was -16.22%. The stock price of OCUL is moving down from its 20 days moving average with -15.50% and isolated negatively from 50 days moving average with -20.30%.